Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety of and Immune Response of a 2-Dose Regimen of rDEN1delta30 Dengue Virus Vaccine
This study is currently recruiting participants.
Study NCT00473135   Information provided by National Institute of Allergy and Infectious Diseases (NIAID)
First Received: May 11, 2007   Last Updated: January 15, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Dengue
Additional conditions recognized in this trial
Dengue Hemorrhagic Fever
More general conditions related to this trial
Arbovirus Infections
Flaviviridae Infections
Flavivirus Infections
Hemorrhagic Fevers, Viral
RNA Virus Infections
Virus Diseases
Interventions listed in this trial
rDEN1delta30
Placebo
Sponsors listed in this trial
National Institute of Allergy and Infectious Diseases (NIAID)
Center for Immunization Research


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services